242 related articles for article (PubMed ID: 31293521)
1. The Nuclear Receptor-Co-repressor Complex in Control of Liver Metabolism and Disease.
Liang N; Jakobsson T; Fan R; Treuter E
Front Endocrinol (Lausanne); 2019; 10():411. PubMed ID: 31293521
[TBL] [Abstract][Full Text] [Related]
2. PPARα and NCOR/SMRT corepressor network in liver metabolic regulation.
Kang Z; Fan R
FASEB J; 2020 Jul; 34(7):8796-8809. PubMed ID: 32396271
[TBL] [Abstract][Full Text] [Related]
3. TBLR1 regulates the expression of nuclear hormone receptor co-repressors.
Zhang XM; Chang Q; Zeng L; Gu J; Brown S; Basch RS
BMC Cell Biol; 2006 Aug; 7():31. PubMed ID: 16893456
[TBL] [Abstract][Full Text] [Related]
4. Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases.
Paluvai H; Shanmukha KD; Tyedmers J; Backs J
Front Mol Biosci; 2023; 10():1190094. PubMed ID: 37674539
[TBL] [Abstract][Full Text] [Related]
5. Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication.
Dreer M; Fertey J; van de Poel S; Straub E; Madlung J; Macek B; Iftner T; Stubenrauch F
PLoS Pathog; 2016 Apr; 12(4):e1005556. PubMed ID: 27064408
[TBL] [Abstract][Full Text] [Related]
6. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
Serviddio G; Bellanti F; Vendemiale G
Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
[TBL] [Abstract][Full Text] [Related]
7. Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.
Moya M; Gómez-Lechón MJ; Castell JV; Jover R
Chem Biol Interact; 2010 Mar; 184(3):376-87. PubMed ID: 20079722
[TBL] [Abstract][Full Text] [Related]
8. ERRα as a Bridge Between Transcription and Function: Role in Liver Metabolism and Disease.
Xia H; Dufour CR; Giguère V
Front Endocrinol (Lausanne); 2019; 10():206. PubMed ID: 31024446
[TBL] [Abstract][Full Text] [Related]
9. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation.
Ogawa S; Lozach J; Jepsen K; Sawka-Verhelle D; Perissi V; Sasik R; Rose DW; Johnson RS; Rosenfeld MG; Glass CK
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14461-6. PubMed ID: 15452344
[TBL] [Abstract][Full Text] [Related]
10. Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease.
Kim SG; Kim BK; Kim K; Fang S
Endocrinol Metab (Seoul); 2016 Dec; 31(4):500-504. PubMed ID: 28029021
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptor repression: regulatory mechanisms and physiological implications.
Stewart MD; Wong J
Prog Mol Biol Transl Sci; 2009; 87():235-59. PubMed ID: 20374706
[TBL] [Abstract][Full Text] [Related]
12. Role of co-regulators in metabolic and transcriptional actions of thyroid hormone.
Astapova I
J Mol Endocrinol; 2016 Apr; 56(3):73-97. PubMed ID: 26673411
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems.
Soto-Gutierrez A; Gough A; Vernetti LA; Taylor DL; Monga SP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1605-1616. PubMed ID: 28467181
[TBL] [Abstract][Full Text] [Related]
14. Nuclear receptors and nonalcoholic fatty liver disease.
Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
[TBL] [Abstract][Full Text] [Related]
15. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
Li X; Wang Z; Klaunig JE
Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929
[TBL] [Abstract][Full Text] [Related]
16. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
17. NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.
Zhuang Q; Li W; Benda C; Huang Z; Ahmed T; Liu P; Guo X; Ibañez DP; Luo Z; Zhang M; Abdul MM; Yang Z; Yang J; Huang Y; Zhang H; Huang D; Zhou J; Zhong X; Zhu X; Fu X; Fan W; Liu Y; Xu Y; Ward C; Khan MJ; Kanwal S; Mirza B; Tortorella MD; Tse HF; Chen J; Qin B; Bao X; Gao S; Hutchins AP; Esteban MA
Nat Cell Biol; 2018 Apr; 20(4):400-412. PubMed ID: 29531310
[TBL] [Abstract][Full Text] [Related]
18. Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors.
Gehrke N; Wörns MA; Huber Y; Hess M; Straub BK; Hövelmeyer N; Waisman A; Kim YO; Schuppan D; Galle PR; Schattenberg JM
J Hepatol; 2016 Dec; 65(6):1188-1197. PubMed ID: 27405060
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the SMRT/NCoR-HDAC3 complex in transcriptional repression by the CNOT2 subunit of the human Ccr4-Not complex.
Jayne S; Zwartjes CG; van Schaik FM; Timmers HT
Biochem J; 2006 Sep; 398(3):461-7. PubMed ID: 16712523
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide studies of nuclear receptors in cell fate decisions.
Mendoza-Parra MA; Gronemeyer H
Semin Cell Dev Biol; 2013 Dec; 24(10-12):706-15. PubMed ID: 23916718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
